Does OFATUMUMAB Cause Injection site erythema? 200 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Injection site erythema have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.7% of all adverse event reports for OFATUMUMAB.
200
Reports of Injection site erythema with OFATUMUMAB
0.7%
of all OFATUMUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Injection site erythema From OFATUMUMAB?
Of the 200 reports, 6 (3.0%) required hospitalization, and 3 (1.5%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 200 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which OFATUMUMAB Alternatives Have Lower Injection site erythema Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB